Catalogo dei prodotti della ricerca

MILANO, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 979
EU - Europa 371
AS - Asia 119
AF - Africa 9
SA - Sud America 9
Totale 1.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 956
IT - Italia 124
SE - Svezia 79
IN - India 57
CN - Cina 38
FI - Finlandia 38
DE - Germania 29
UA - Ucraina 29
CA - Canada 23
GB - Regno Unito 20
SG - Singapore 20
BE - Belgio 13
AR - Argentina 9
IE - Irlanda 9
BG - Bulgaria 7
TG - Togo 7
FR - Francia 5
HU - Ungheria 4
JP - Giappone 4
RO - Romania 4
AL - Albania 3
NL - Olanda 3
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
MA - Marocco 1
PL - Polonia 1
SC - Seychelles 1
Totale 1.487
Salva come PNG Salva come JPEG
Città #
Fairfield 103
Chandler 97
Woodbridge 89
Ashburn 64
Ann Arbor 59
Rome 56
Cambridge 49
Seattle 47
Houston 44
Wilmington 43
Princeton 26
Dearborn 25
Plano 25
San Paolo di Civitate 18
Beijing 17
Ottawa 17
New York 14
Brussels 13
Helsinki 13
Lawrence 13
Millbury 11
Dublin 10
Jacksonville 10
San Diego 10
Federal 9
Boston 8
Fremont 8
Singapore 8
Des Moines 7
Lomé 7
San Mateo 7
Sofia 7
Milan 6
Norwalk 6
Andover 5
Redwood City 5
Bremen 4
Hefei 4
Boardman 3
Chengdu 3
Los Angeles 3
Phoenix 3
Rho 3
Toronto 3
Budapest 2
Ceccano 2
Florence 2
Fuzhou 2
Genova 2
Jinan 2
Leawood 2
Loreto 2
Monte Porzio Catone 2
Napoli 2
Redmond 2
Riva 2
Serra 2
Snohomish 2
Tampere 2
Arzano 1
Atlanta 1
Auburn Hills 1
Bern 1
Bristol 1
Büdelsdorf 1
Bühl 1
Campobasso 1
Clearwater 1
Cleveland 1
Cordenons 1
Edinburgh 1
Flushing 1
Groningen 1
Guangzhou 1
Hebei 1
Hounslow 1
Hyderabad 1
Ivry-sur-seine 1
Kunming 1
Las Vegas 1
Lissone 1
London 1
Madrid 1
Montclair 1
Nanjing 1
New Delhi 1
New Orleans 1
Nürnberg 1
Paris 1
Pune 1
Sacramento 1
Secaucus 1
Shanghai 1
Shenyang 1
Sherbrooke 1
Southend 1
Southwark 1
Stockholm 1
Surrey 1
Tokyo 1
Totale 1.053
Salva come PNG Salva come JPEG
Nome #
Circulating tumor cells count predicts survival in colorectal cancer patients. 103
Lenalidomide in multiple myeloma: current experimental and clinical data. 98
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer 88
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient 83
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study 80
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety 79
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy 78
mthfr c677t gene polymorphisms And susceptibility to cArdiovAsculAr Adverse events in metAstAtic colorectAl cAncer treAted with chemotherApy plus bevAcizumAb 70
null 68
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice 68
null 61
Le metastasi ossee: aspetti patogenetici e clinici. 58
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial 56
Targeted Therapies in Cancer 54
PD-0001CAN WE PREDICT TIME TO TUMOR PROGRESSION IN EARLY COLORECTAL CANCER PATIENTS USING CTCS COUNT? 54
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life” 47
null 46
null 42
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? 40
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” 40
Resistance to abiraterone in castration-resistant prostate cancer: a review of the literature. 37
Lapatinib nel tumore mammario metastatico HER2-positivo. suggerimenti dall’ Esmo 2014 36
Epithelial and mesenchymal molecular markers in circulating tumor cells (CTCs) from non small cells lung cancer (NSCLC) patients. 34
Cancer stem cells in Multiple Myeloma 31
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know. 29
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer 18
Somatic NGS Analysis of DNA Damage Response (DDR) Genes ATM, MRE11A, RAD50, NBN, and ATR in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemo-Radiotherapy 17
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer 15
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 13
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours 11
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial 8
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art 5
Totale 1.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201989 0 0 0 0 0 0 0 0 0 0 50 39
2019/2020310 41 10 2 14 28 48 47 38 29 22 16 15
2020/2021132 21 13 5 6 21 13 3 8 16 6 15 5
2021/2022252 0 11 22 7 35 7 7 28 26 19 45 45
2022/2023368 52 60 23 35 39 42 11 43 33 3 21 6
2023/2024118 9 25 4 9 21 22 1 12 0 12 3 0
Totale 1.567